2008 Annual Meeting | Developing Neuroprotective Therapies
07:30 PM - 08:20 PM |
Translation Toward Effective ALS Therapies
Robert H. Brown, Jr., MD, DPhil |
|
08:20 PM - 09:10 PM |
Disease-Modifying Treatments for Alzheimer's Disease
|
|
09:10 PM - 09:20 PM |
Break
|
|
09:20 PM - 10:10 PM |
Neuroprotectants for Parkinson's Disease
Paul S. Fishman, MD, PhD |
|
10:10 PM - 10:30 PM |
Discussion
|
Paul S. Fishman, MD, PhD | No disclosure on file |
Robert H. Brown, Jr., MD, DPhil | Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has stock in ApicBio. Dr. Brown has stock in Amylx. Dr. Brown has stock in Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care. |